Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(2 Suppl 1):4–9. https://doi.org/10.1016/J.BONE.2005.11.024.
Gossiel F, Altaher H, Reid DM, et al. Bone turnover markers after the menopause: T-score approach. Bone. 2018;111:44–8. https://doi.org/10.1016/J.BONE.2018.03.016.
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33. https://doi.org/10.1007/S00198-006-0172-4.
Article CAS PubMed Google Scholar
Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep. 2010;12(3):186–91. https://doi.org/10.1007/S11926-010-0097-Y.
Carlos F, Clark P, Galindo-Suárez RM, Chico-Barba LG. Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos. 2013;8(1):125. https://doi.org/10.1007/S11657-013-0125-4.
Aziziyeh R, Amin M, Habib M, et al. A scorecard for osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. Arch Osteoporos. 2019;14(1):69. https://doi.org/10.1007/S11657-019-0622-1.
Albergaria BH, Chalem M, Clark P, Messina OD, Pereira RMR, Vidal LF. Consensus statement: osteoporosis prevention and treatment in Latin America—current structure and future directions. Arch Osteoporos. 2018;13(1):90. https://doi.org/10.1007/S11657-018-0505-X.
Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol. 2018;4(1):12. https://doi.org/10.1186/S40842-018-0062-7.
Zhang AH, Sun H, Yan GL, Han Y, Wang XJ. Serum proteomics in biomedical research: a systematic review. Appl Biochem Biotechnol. 2013;170(4):774–86. https://doi.org/10.1007/S12010-013-0238-7.
Article CAS PubMed Google Scholar
Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318. https://doi.org/10.1186/S13018-021-02474-7.
Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int. 2008;19(12):1683–704. https://doi.org/10.1007/S00198-008-0660-9.
Article CAS PubMed Google Scholar
Deutsch EW, Omenn GS, Sun Z, et al. Advances and utility of the human plasma proteome. J Proteome Res. 2021;20(12):5241–63. https://doi.org/10.1021/ACS.JPROTEOME.1C00657.
Article CAS PubMed PubMed Central Google Scholar
Greco V, Piras C, Pieroni L, Urbani A. Direct assessment of plasma/serum sample quality for proteomics biomarker investigation. Methods Mol Biol. 2017;1619:3–21. https://doi.org/10.1007/978-1-4939-7057-5_1.
Article CAS PubMed Google Scholar
Deng FY, Liu YZ, Li LM, et al. Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density. Proteomics. 2008;8(20):4259–72. https://doi.org/10.1002/PMIC.200700480.
Article CAS PubMed PubMed Central Google Scholar
Lv M, Cui C, Chen P, Li Z. Identification of osteoporosis markers through bioinformatic functional analysis of serum proteome. Medicine. 2020;99(39):e22172. https://doi.org/10.1097/MD.0000000000022172.
Article CAS PubMed PubMed Central Google Scholar
Huang D, Wang Y, Lv J, et al. Proteomic profiling analysis of postmenopausal osteoporosis and osteopenia identifies potential proteins associated with low bone mineral density. PeerJ. 2020;8:e9009. https://doi.org/10.7717/PEERJ.9009/SUPP-8.
Zhang Ll, Li Cw, Liu K, et al. Discovery and identification of serum succinyl-proteome for postmenopausal women with osteoporosis and osteopenia. Orthop Surg. 2019;11(5):784–93. https://doi.org/10.1111/OS.12519.
Article PubMed PubMed Central Google Scholar
Hlaing TT, Compston JE. Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem. 2014;51(Pt 2):189–202. https://doi.org/10.1177/0004563213515190.
Martínez-Aguilar MM, Aparicio-Bautista DI, Ramírez-Salazar EG, et al. Serum proteomic analysis reveals vitamin D-binding protein (VDBP) as a potential biomarker for low bone mineral density in Mexican postmenopausal women. Nutrients. 2019;11(12):2853. https://doi.org/10.3390/NU11122853.
Denova-Gutiérrez E, Flores YN, Gallegos-Carrillo K, et al. Health workers cohort study: methods and study design. Salud Publica Mex. 2016;58(6):708–16. https://doi.org/10.21149/SPM.V58I6.8299.
Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int. 2000;11(3):192–202. https://doi.org/10.1007/S001980050281.
Article CAS PubMed Google Scholar
Kanis JA, Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368–81. https://doi.org/10.1007/BF01622200.
Article CAS PubMed Google Scholar
Ortega-Lozano AJ, Jiménez-Uribe AP, Aranda-Rivera AK, et al. Expression profiles of kidney mitochondrial proteome during the progression of the unilateral ureteral obstruction: focus on energy metabolism adaptions. Metabolites. 2022;12(10):936. https://doi.org/10.3390/METABO12100936.
Rios-Castro E, Souza GHMF, Delgadillo-Alvarez DM, et al. Quantitative proteomic analysis of MARC-145 cells infected with a Mexican porcine reproductive and respiratory syndrome virus strain using a label-free based DIA approach. J Am Soc Mass Spectrom. 2020;31(6):1302–12. https://doi.org/10.1021/JASMS.0C00134.
Article CAS PubMed Google Scholar
Li GZ, Vissers JPC, Silva JC, Golick D, Gorenstein MV, Geromanos SJ. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics. 2009;9(6):1696–719. https://doi.org/10.1002/PMIC.200800564.
Article CAS PubMed Google Scholar
Käll L, Storey JD, MacCoss MJ, Noble WS. Assigning significance to peptides identified by tandem mass spectrometry using decoy databases. J Proteome Res. 2008;7(1):29–34. https://doi.org/10.1021/PR700600N.
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7. https://doi.org/10.1089/OMI.2011.0118.
Article CAS PubMed PubMed Central Google Scholar
Al-Ansari MM, Aleidi SM, Masood A, et al. Proteomics profiling of osteoporosis and osteopenia patients and associated network analysis. Int J Mol Sci. 2022;23(17):10200. https://doi.org/10.3390/IJMS231710200.
Huo C, Li Y, Qiao Z, et al. Comparative proteomics analysis of microvesicles in human serum for the evaluation of osteoporosis. Electrophoresis. 2019;40(14):1839–47. https://doi.org/10.1002/ELPS.201900130.
Article CAS PubMed Google Scholar
Nielson CM, Wiedrick J, Shen J, et al. Identification of hip BMD loss and fracture risk markers through population-based serum proteomics. J Bone Miner Res. 2017;32(7):1559–67. https://doi.org/10.1002/JBMR.3125.
Article CAS PubMed Google Scholar
Chen M, Li Y, Lv H, Yin P, Zhang L, Tang P. Quantitative proteomics and reverse engineer analysis identified plasma exosome derived protein markers related to osteoporosis. J Proteomics. 2020;228:103940. https://doi.org/10.1016/J.JPROT.2020.103940.
Cawthon PM, Ewing SK, McCulloch CE, et al. Loss of hip BMD in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res. 2009;24(10):1728. https://doi.org/10.1359/JBMR.090419.
Article PubMed PubMed Central Google Scholar
Adebanjo OA, Biswas G, Moonga BS, et al. Novel biochemical and functional insights into nuclear Ca(2+) transport through IP(3)Rs and RyRs in osteoblasts. Am J Physiol Renal Physiol. 2000;278(5):F784-91. https://doi.org/10.1152/AJPRENAL.2000.278.5.F784.
Wei H, Bi Y, Wang Y, et al. Serum bone remodeling parameters and transcriptome profiling reveal abnormal bone metabolism associated with keel bone fractures in laying hens. Poult Sci. 2023;102(4):102438. https://doi.org/10.1016/J.PSJ.2022.102438.
Robinson LJ, Blair HC, Barnett JB, Zaidi M, Huang CLH. Regulation of bone turnover by calcium-regulated calcium channels. Ann N Y Acad Sci. 2010;1192:351–7. https://doi.org/10.1111/J.1749-6632.2009.05219.X.
Article CAS PubMed Google Scholar
Tao X, Liu L, Yang X, et al. Clinical characteristics and pathogenic gene identification in Chinese patients with Paget’s disease of bone. Front Endocrinol (Lausanne). 2022;13:850462. https://doi.org/10.3389/FENDO.2022.850462.
Tariq E, Mirza L. Early osteoporosis in RYR1-related central core disease. J Endocr Soc. 2021;5(Suppl 1):A191. https://doi.org/10.1210/JENDSO/BVAB048.387.
Article PubMed Central Google Scholar
Chen ZH, Wu JJ, Guo DY, et al. Physiological functions of podosomes: from structure and function to therapy implications in osteoclast biology of bone resorption. Ageing Res Rev. 2023;85:101842. https://doi.org/10.1016/J.ARR.2023.101842.
Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol. 2000;148(4):665–78. https://doi.org/10.1083/JCB.148.4.665.
Article CAS PubMed PubMed Central Google Scholar
Wang WY, Ge B, Shi J, et al. Plasma gelsolin is associated with hip BMD in Chinese postmenopausal women. PLoS One. 2018;13(5):e0197732. https://doi.org/10.1371/JOURNAL.PONE.0197732.
Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D. Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci. 2004;61(19–20):2614–23. https://doi.org/10.1007/S00018-004-4225-6.
Article CAS PubMed Google Scholar
Saltel F, Chabadel A, Bonnelye E, Jurdic P. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol. 2008;87(8–9):459–68. https://doi.org/10.1016/J.EJCB.2008.01.001.
Article CAS PubMed Google Scholar
Toroian D, Price PA. The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int. 2008;82(2):116–26. https://doi.org/10.1007/S00223-007-9085-2.
Article CAS PubMed Google Scholar
Özkan E, Özkan H, Bilgiç S, et al. Serum fetuin-A levels in postmenopausal women with osteoporosis. Turk J Med Sci. 2014;44(6):985–8. https://doi.org/10.3906/SAG-1308-28.
Schäfer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112(3):357–66. https://doi.org/10.1172/JCI17202.
留言 (0)